Ventilator-associated pneumonia: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
|||
| Line 1: | Line 1: | ||
{{Ventilator-associated pneumonia}} | {{Ventilator-associated pneumonia}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto: | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | ||
==[[Ventilator-associated pneumonia overview|Overview]]== | ==[[Ventilator-associated pneumonia overview|Overview]]== | ||
==[[Ventilator-associated pneumonia historical perspective|Historical Perspective]]== | ==[[Ventilator-associated pneumonia historical perspective|Historical Perspective]]== | ||
Revision as of 18:50, 2 November 2012
Template:Ventilator-associated pneumonia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differential diagnosis
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray
Treatment
Recommendations for clinical strategy | Medical Therapy | Prevention | Assessing response to therapy